VTX-1218

N/A

Report date: 2022/01/07 15:40:37

Base Information

Drug NameVTX-1218
Drug Alias NameVTX-1218
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-V-set and immunoglobulin domain-containing protein 4
TargetsV-set and immunoglobulin domain-containing protein 4
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator Companies3sbio IncVerseau Therapeutics Inc
China Registration ClassN/A

Develop Information

Active Companies3sbio IncVerseau Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A